How does AMBU B's PE Ratio compare to its peers?

AMBU B is expensive based on its Price-To-Earnings Ratio (127.5x) compared to the peer average (29.9x).

How does AMBU B's PE Ratio compare vs other companies in the European Medical Equipment Industry?

AMBU B is expensive based on its Price-To-Earnings Ratio (127.5x) compared to the European Medical Equipment industry average (28.9x).

What is AMBU B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AMBU B is expensive based on its Price-To-Earnings Ratio (127.5x) compared to the estimated Fair Price-To-Earnings Ratio (43.4x).

What is the Fair Price of AMBU B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

AMBU B (DKK112.5) is trading below our estimate of [[fair value]] (DKK123.34)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is less than 20% higher than the current share price.

Ambu (CPSE:AMBU B) - Stock Price, News & Analysis

AMBU B Stock Overview

A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details

AMBU B fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 8.8% below our estimate of its fair value

Earnings are forecast to grow 28.05% per year

Earnings grew by 39.9% over the past year

Risk Analysis

Large one-off items impacting financial results

Volatile share price over the past 3 months compared to the Danish market

Ambu A/S Competitors

Demant

CPSE:DEMANT

DKK 56.5b

Embla Medical hf

CPSE:EMBLA

DKK 15.3b

Coloplast

CPSE:COLO B

DKK 198.3b

Getinge

OM:GETI B

SEK 45.4b

Price History & Performance

Summary of all time highs, changes and price drops for Ambu
Historical stock prices
Current Share Price	DKK 112.50
52 Week High	DKK 154.60
52 Week Low	DKK 88.02
Beta	0.79
11 Month Change	-12.79%
3 Month Change	-24.98%
1 Year Change	24.64%
33 Year Change	-41.07%
5 Year Change	-3.47%
Change since IPO	6,469.35%

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07

Recent updates

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Nov 13

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Nov 07

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Jan 02

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Oct 31

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 22

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Aug 19

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Jul 12

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Jun 22

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

May 07

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Mar 24

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Jan 20

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

Dec 08

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Sep 23

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Sep 08

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Aug 21

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Jun 06

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

May 19

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Jan 23

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Dec 12

Shareholder Returns

	AMBU B	DK Medical Equipment	DK Market
7D	-5.1%	-0.3%	-1.0%
1Y	24.6%	10.9%	7.5%

Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned 14% over the past year.

Return vs Market: AMBU B exceeded the Danish Market which returned 6.2% over the past year.

Price Volatility

Is AMBU B's price volatile compared to industry and market?
AMBU B volatility
AMBU B Average Weekly Movement	6.8%
Medical Equipment Industry Average Movement	3.6%
Market Average Movement	4.2%
10% most volatile stocks in DK Market	10.5%
10% least volatile stocks in DK Market	2.5%

Stable Share Price: AMBU B's share price has been volatile over the past 3 months compared to the Danish market.

Volatility Over Time: AMBU B's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Danish stocks.

About the Company

Founded	Employees	CEO	Website
1937	5,196	Britt Jensen	www.ambu.com

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Ambu A/S Fundamentals Summary

How do Ambu's earnings and revenue compare to its market cap?
AMBU B fundamental statistics
Market cap	DKK 29.97b
Earnings (TTM)	DKK 235.00m
Revenue (TTM)	DKK 5.39b

127.5x

P/E Ratio

5.6x

P/S Ratio

Is AMBU B overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBU B income statement (TTM)
Revenue	DKK 5.39b
Cost of Revenue	DKK 2.19b
Gross Profit	DKK 3.20b
Other Expenses	DKK 2.97b
Earnings	DKK 235.00m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Jan 30, 2025

Earnings per share (EPS)	0.88
Gross Margin	59.38%
Net Profit Margin	4.36%
Debt/Equity Ratio	0%

How did AMBU B perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

43%

Payout Ratio

Does AMBU B pay a reliable dividends?

See AMBU B dividend history and benchmarks

When do you need to buy AMBU B by to receive an upcoming dividend?
Ambu dividend dates
Ex Dividend Date	Dec 05 2024
Dividend Pay Date	Dec 09 2024
Days until Ex dividend	13 days
Days until Dividend pay date	17 days

Does AMBU B pay a reliable dividends?

See AMBU B dividend history and benchmarks

AMBU B Stock Overview

Rewards

Risk Analysis

Ambu A/S Competitors

CPSE:DEMANT

DKK 56.5b

CPSE:EMBLA

DKK 15.3b

CPSE:COLO B

DKK 198.3b

OM:GETI B

SEK 45.4b

Price History & Performance

Recent News & Updates

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Ambu A/S Proposes Dividend

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Full year 2024 earnings: EPS misses analyst expectations

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Recent updates

Ambu's (CPH:AMBU B) Strong Earnings Are Of Good Quality

Ambu A/S Proposes Dividend

Earnings Miss: Ambu A/S Missed EPS By 54% And Analysts Are Revising Their Forecasts

Full year 2024 earnings: EPS misses analyst expectations

Ambu A/S, Annual General Meeting, Dec 03, 2025

Ambu A/S to Report Q1, 2025 Results on Jan 30, 2025

Ambu A/S Just Beat EPS By 15%: Here's What Analysts Think Will Happen Next

Third quarter 2024 earnings: EPS exceeds analyst expectations

Price target increased by 8.1% to kr.123

Here's What's Concerning About Ambu's (CPH:AMBU B) Returns On Capital

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations